Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;58(5):469-476.
doi: 10.1177/15385744231225802. Epub 2023 Dec 29.

Quality of Life after Venous Stenting for Post-thrombotic Syndrome and the Effect of Inflow Disease

Jay M Bakas  1 , Catherine van Montfrans  2 , Adriaan Moelker  3 , Renate R van den Bos  2 , Wendy S J Malskat  2 , Hence J M Verhagen  1 , Marie Josee E van Rijn  1   2
Affiliations

Quality of Life after Venous Stenting for Post-thrombotic Syndrome and the Effect of Inflow Disease

Jay M Bakas et al. Vasc Endovascular Surg. 2024 Jul.

Abstract

Objective: Patients with PTS experience an impaired quality of life (QoL). We aimed to study QoL in patients stented for post thrombotic syndrome (PTS) and analyze the influence of different parameters.

Methods: Patients stented for PTS after iliofemoral deep vein thrombosis were asked to complete the Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20) and the Short Form Health Survey (SF-36) in this cross-sectional study. All other data were collected retrospectively. Primary endpoints were median CIVIQ-20 and physical (PCS) and mental (MCS) component summary SF-36 scores. The influence of age, sex, and years between the procedure and completion of questionnaire were investigated using a multivariate linear regression model. Wilcoxon signed rank test compared the PCS and MCS with the normative. Effects of inflow from the deep femoral vein (DFV) and/or the femoral vein (FV) on QoL was analyzed in patients with patent stents.

Results: The response rate was 70.3% (n = 45/64). Time period (median) from stenting to questionnaire completion was 6.6 years (IQR: 8.0). Most stents were placed unilateral left-sided (73.3%). For patients with patent stents (n = 42) median CIVIQ-20 was 35.5 (IQR: 17.3), higher than the minimum of 20.0 (P < .001). Median PCS of 44.7 (IQR: 14.2) was lower (P < .001), and MCS of 55.9 (IQR: 7.1) higher (P = .001) than the normative (50.0). Time since stenting and sex were not associated with QoL. Age was a significant predictor [standardized coefficient ß = .36, P = .04] for QoL using the CIVIQ-20, but not for the SF-36. Inflow disease did not impact QoL, but patients with occluded stents (n = 3) had poor functioning levels.

Conclusion: Quality of life is impaired after venous stenting for PTS, particularly physical functioning, among patients with an open stent, but was similar between patients with good and impaired inflow. Patients with a permanent stent occlusion had the lowest QoL.

Keywords: long-term outcomes; patient reported outcomes; postthrombotic syndrome; quality of life; stents.

PubMed Disclaimer

Conflict of interest statement

Declarations of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: AM and MR reported conflicting interests. AM is a proctor and speaker for Cook Medical and advisor for Angiocare. MR is a speaker for Medtronic and Inari.

Figures

Figure 1.
Figure 1.
Flowchart patient inclusion.
Figure 2.
Figure 2.
Patient-reported outcome measures in patients with open and occluded venous stents. (A): Total CIVIQ-20 scores plotted against years between the primary procedure and completion of the questionnaire in years. (B): Total SF-36 physical component summary plotted against years between the primary procedure and completion of the questionnaire in years. (C): Total SF-36 mental component summary plotted against years between the primary procedure and completion of the questionnaire in years.
See this image and copyright information in PMC

References

    1. Galanaud JP, Monreal M, Kahn SR. Epidemiology of the post-thrombotic syndrome. Thromb Res. 2018;164:100-109. doi:10.1016/j.thromres.2017.07.026 - DOI - PubMed
    1. Schulman S, Lindmarker P, Holmström M, et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemostasis. 2006;4(4):734-742. - PubMed
    1. Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med. 1997;126(6):454-457. doi:10.7326/0003-4819-126-6-199703150-00006 - DOI - PubMed
    1. Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemostasis. 2008;6(7):1105-1112. doi:10.1111/j.1538-7836.2008.03002.x - DOI - PubMed
    1. De Maeseneer MG, Kakkos SK, Aherne T, et al. Corrigendum to European Society for Vascular Surgery (ESVS) 2022 Clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg. 2022;64:284-285. - PubMed

MeSH terms